Cargando…

Expression of LAG-3 defines exhaustion of intratumoral PD-1(+) T cells and correlates with poor outcome in follicular lymphoma

Exhausted T-cells in follicular lymphoma (FL) typically express PD-1, but expression of PD-1 is not limited to exhausted cells. Although expected to be functionally suppressed, we found that the population of intratumoral PD-1(+) T cells were predominantly responsible for production of cytokines and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhi-Zhang, Kim, Hyo Jin, Villasboas, Jose C., Chen, Ya-Ping, Price-Troska, Tammy, Jalali, Shahrzad, Wilson, Mara, Novak, Anne J., Ansell, Stephen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617435/
https://www.ncbi.nlm.nih.gov/pubmed/28977875
http://dx.doi.org/10.18632/oncotarget.18251
Descripción
Sumario:Exhausted T-cells in follicular lymphoma (FL) typically express PD-1, but expression of PD-1 is not limited to exhausted cells. Although expected to be functionally suppressed, we found that the population of intratumoral PD-1(+) T cells were predominantly responsible for production of cytokines and granules. This surprising finding prompted us to explore the involvement of LAG-3 to specifically identify functionally exhausted T cells. We found that LAG-3 was expressed on a subset of intratumoral T cells from FL and LAG-3(+) T cells almost exclusively came from PD-1(+) population. CyTOF analysis revealed that intratumoral LAG-3(+) T cells were phenotypically heterogeneous as LAG-3 was expressed on a variety of T cell subsets. In contrast to PD-1(+)LAG-3(-) cells, intratumoral PD-1(+)LAG-3(+) T cells exhibited reduced capacity to produce cytokines and granules. LAG-3 expression could be substantially upregulated on CD4(+) or CD8(+) T cells by IL-12, a cytokine that has been shown to induce T-cell exhaustion and be increased in the serum of lymphoma patients. Furthermore, we found that blockade of both PD-1 and LAG-3 signaling enhanced the function of intratumoral CD8(+) T cells resulting in increased IFN-γ and IL-2 production. Clinically, LAG-3 expression on intratumoral T cells correlated with a poor outcome in FL patients. Taken together, we find that LAG-3 expression is necessary to identify the population of intratumoral PD-1(+) T cells that are functionally exhausted and, in contrast, find that PD-1(+)LAG-3(-) T cells are simply activated cells that are immunologically functional. These findings may have important implications for immune checkpoint therapy in FL.